A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma

Clinical trial NCT03339219 · COMPLETED

Trial details

NCT number: NCT03339219
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Renal Cell Carcinoma

Start date: 2017-12-13
Primary completion: 2020-08-25
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.